| Announce Date | 10/27/2025 | 
| EPS Normalized Actual | $2.31 (Beat by $0.84) | 
| EPS GAAP Actual | $2.31 (Beat by $0.84) | 
| Revenue Actual | $3.15859B | 
| Revenue Surprise | Beat by $3158.59M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.92037 | 
| EPS GAAP Estimate | $0.92037 | 
| Revenue Estimate | $2.516627926B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2028 | 11.13401 | 31.35 | 10.883 | 11.32532 | 2 | 
| Dec 2027 | 6.67773 | 52.26 | 6.37631 | 6.98466 | 2 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.33 | 1.42132 | 3.15859B | 20.23% | 669.65M | 
| FQ2 2025 (Jun 2025) | 1.83 | 1.05197 | 2.8934B | 17.35% | 575.51M | 
| FQ1 2025 (Mar 2025) | 0.74 | 0.74 | 2.6486B | 16.97% | 2648.6M | 
| FQ4 2024 (Dec 2024) | 1.3 | 1.3 | 2.5457B | 13.59% | 2545.7M | 
| FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 2.51961B | 18.9% | 2519.61M | 
| FQ2 2024 (Jun 2024) | 0.84 | 0.84 | 2.39141B | 18.9% | 2391.41M | 
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 2.19903B | 16.43% | 2199.03M | 
| FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 2.19966B | 7.14% | 2199.66M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.92037
Consensus Revenue Estimates
2.516627926B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.0871 | -- | 2.06229 | 2.15764 | 4 | 
| FQ3 2027 (Sep 2027) | 1.62449 | -- | 1.61361 | 1.6352 | 1 | 
| FQ2 2027 (Jun 2027) | 1.51384 | -- | 1.5037 | 1.52382 | 1 | 
| FQ1 2027 (Mar 2027) | 1.47486 | -- | 1.45977 | 1.49952 | 2 | 
| FQ4 2026 (Oct 2026) | 0.9502 | -- | 0.94088 | 0.963 | 1 | 
| FQ3 2026 (Jul 2026) | 0.96694 | -140.97 | 0.95745 | 0.97997 | 1 | 
| FQ2 2026 (Jun 2026) | 0.8608 | -112.59 | 0.8445 | 0.88306 | 1 | 
| FQ1 2026 (Mar 2026) | 0.98809 | 25.11 | 0.9667 | 1.00921 | 3 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.03B | -- | 4B | 4.14B | 5 | 
| FQ3 2027 (Sep 2027) | 3.43B | -- | 3.41B | 3.45B | 1 | 
| FQ2 2027 (Jun 2027) | 3.25B | -- | 3.23B | 3.26B | 1 | 
| FQ1 2027 (Mar 2027) | 3.19B | -- | 3.17B | 3.23B | 2 | 
| FQ4 2026 (Oct 2026) | 2.69B | -- | 2.67B | 2.71B | 2 | 
| FQ3 2026 (Jul 2026) | 2.65B | -19.27 | 2.63B | 2.68B | 2 | 
| FQ2 2026 (Jun 2026) | 2.4B | -20.48 | 2.37B | 2.45B | 2 | 
| FQ1 2026 (Mar 2026) | 2.59B | -2.34 | 2.54B | 2.63B | 1 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.90868 | 2.33 | 1.42132 | 61% | 
| FQ2 2025 (Jun 2025) | 0.77803 | 1.83 | 1.05197 | 57.48% | 
| FQ1 2025 (Mar 2025) | 0.74 | 0.74 | 100% | |
| FQ4 2024 (Dec 2024) | 1.3 | 1.3 | 100% | |
| FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 100% | |
| FQ2 2024 (Jun 2024) | 0.84 | 0.84 | 100% | |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% | |
| FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.49B | $3.16B | $669.65M | 21.2% | 
| FQ2 2025 (Jun 2025) | $2.32B | $2.89B | $575.51M | 19.89% | 
| FQ1 2025 (Mar 2025) | $0B | $2.65B | $2648.6M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $2.55B | $2545.7M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $2.52B | $2519.61M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $2.39B | $2391.41M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $2.2B | $2199.03M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $2.2B | $2199.66M | 100% |